Serial CEA and CA 15-3 measurements during follow-up of breast cancer patients

Anticancer Research

Volumn 20, Issue 6 D, 2000, Pages 5179-5182

  Jager W ^a   Eibner, K ^a   Loffler B ^a   Gleixner, S ^a   Kramer S ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Breast cancer; CA 15 3; CEA

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

BREAST CANCER; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; PATIENT EDUCATION; PATIENT MONITORING; PRIORITY JOURNAL;

BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; FOLLOW-UP STUDIES; HUMANS; POSTOPERATIVE CARE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034452449     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease
2. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer
3. Breast cancer and clinical utility of CA15-3 and CEA
4. CEA and CA15-3 in breast cancer: Their importance in diagnosing primary tumours, local recurrences and distant metastases
5. The value of the tumor marker CA15-3 in diagnosing and monitoring breast cancer
6. Modifizierte Mammakarzinom-Nachsorge
7. Early detection of metastatic breast cancer by tumorassociated antigens
8. Early treatment of metastatic breast cancer patients after increase of CEA and CA15-3 serum levels
9. The therapeutic advantage of early detection of metastasis in patients with breast cancer
10. Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial
11. Intensive diagnostic follow-up after treatment of primary breast cancer: A randomized trial
12. Neue Nachsorgerichtlinien beim Mammakarzinom
13. Erfahrungen in der Nachsorge von Patientinnen mit Mammakarzinom